Analysts Set Cellebrite DI Ltd. (NASDAQ:CLBT) PT at $20.29

Shares of Cellebrite DI Ltd. (NASDAQ:CLBT) have received an average recommendation of “Buy” from the eight research firms that are currently covering the company, Marketbeat.com reports. Eight equities research analysts have rated the stock with a buy recommendation. The average twelve-month price objective among brokers that have covered the stock in the last year is $20.29.

CLBT has been the subject of a number of recent research reports. Needham & Company LLC boosted their price objective on shares of Cellebrite DI from $17.00 to $21.00 and gave the company a “buy” rating in a research report on Thursday, November 7th. JPMorgan Chase & Co. upped their price target on Cellebrite DI from $21.00 to $22.00 and gave the stock an “overweight” rating in a research report on Thursday, November 7th. TD Cowen lifted their price objective on Cellebrite DI from $20.00 to $23.00 and gave the company a “buy” rating in a research report on Monday, September 23rd. Finally, Craig Hallum boosted their price objective on Cellebrite DI from $23.00 to $24.00 and gave the company a “buy” rating in a research note on Thursday, November 7th.

Cellebrite DI Trading Down 0.8 %

Shares of CLBT opened at $19.88 on Friday. The firm has a fifty day simple moving average of $18.93 and a two-hundred day simple moving average of $15.78. The firm has a market cap of $4.09 billion, a PE ratio of -12.83, a P/E/G ratio of 2.71 and a beta of 1.51. Cellebrite DI has a 1-year low of $7.91 and a 1-year high of $21.72.

Cellebrite DI (NASDAQ:CLBT) last posted its quarterly earnings data on Wednesday, November 6th. The company reported $0.14 EPS for the quarter, beating analysts’ consensus estimates of $0.09 by $0.05. The company had revenue of $106.90 million during the quarter, compared to analysts’ expectations of $102.06 million. Cellebrite DI had a positive return on equity of 122.59% and a negative net margin of 82.28%. Cellebrite DI’s revenue for the quarter was up 27.0% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.09 earnings per share. As a group, research analysts forecast that Cellebrite DI will post 0.32 EPS for the current fiscal year.

Institutional Investors Weigh In On Cellebrite DI

Institutional investors have recently added to or reduced their stakes in the stock. California State Teachers Retirement System grew its stake in Cellebrite DI by 9.1% during the first quarter. California State Teachers Retirement System now owns 56,953 shares of the company’s stock valued at $631,000 after acquiring an additional 4,734 shares in the last quarter. Tower View Wealth Management LLC grew its position in shares of Cellebrite DI by 6.2% during the second quarter. Tower View Wealth Management LLC now owns 129,147 shares of the company’s stock valued at $1,543,000 after purchasing an additional 7,542 shares in the last quarter. Concurrent Investment Advisors LLC purchased a new stake in shares of Cellebrite DI in the second quarter worth about $835,000. nVerses Capital LLC purchased a new stake in shares of Cellebrite DI in the second quarter worth about $103,000. Finally, Pembroke Management LTD grew its holdings in Cellebrite DI by 104.9% during the 2nd quarter. Pembroke Management LTD now owns 1,535,726 shares of the company’s stock valued at $18,352,000 after buying an additional 786,310 shares in the last quarter. 45.88% of the stock is owned by hedge funds and other institutional investors.

Cellebrite DI Company Profile

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft.